Analysis of SARS-CoV-2 reverse transcription-quantitative polymerase chain reaction cycle threshold values vis-à-vis anti-SARS-CoV-2 antibodies from a high incidence region. (September 2021)
- Record Type:
- Journal Article
- Title:
- Analysis of SARS-CoV-2 reverse transcription-quantitative polymerase chain reaction cycle threshold values vis-à-vis anti-SARS-CoV-2 antibodies from a high incidence region. (September 2021)
- Main Title:
- Analysis of SARS-CoV-2 reverse transcription-quantitative polymerase chain reaction cycle threshold values vis-à-vis anti-SARS-CoV-2 antibodies from a high incidence region
- Authors:
- Markewitz, Robert
Torge, Antje
Wandinger, Klaus-Peter
Pauli, Daniela
Dargvainiene, Justina
Franke, Andre
Bujanda, Luis
Marimón, José Maria
Banales, Jesus M.
Gutierrez-Stampa, María A.
Nafría, Beatriz
Junker, Ralf - Abstract:
- Highlights: Antibodies against SARS-CoV-2 were associated with lower viral loads of SARS-CoV-2 Higher SARS-CoV-2 viral loads on admission were associated with a fatal outcome Cycle threshold values of different assays and target genes not readily comparable Abstract: Objectives: To examine the relationship between antibody status and cycle threshold (Ct) values, the prognostic value of the latter for COVID-19 patients, and the inter-assay comparability of SARS-CoV-2 Ct values. Methods: In 347 COVID-19 inpatients, SARS-CoV-2 Ct values (via reverse transcription-quantitative polymerase chain reaction) on admission were compared between 2 assays and correlated with the antibody response (in the course of the disease), the clinical course and the time since onset of symptoms. Results: Ct values for 2 of 3 target genes showed significant differences between the 2 assays used ( P =0.012 and P <0.0001). Ct values were significantly higher for antibody positive patients ( P <0.0001) and positively correlated with the amount of time since onset of symptoms (R: 0.332–0.363; P <0.001). Patients with fatal outcomes showed higher viral loads than survivors ( P <0.0001). Conclusions: Ct values depend strongly on assay used and target gene examined and should not be used as quantitative values to guide therapeutic or diagnostic decisions. The inverse association between antibody status and viral load suggests that antibodies contribute to the elimination of the virus, independent of theHighlights: Antibodies against SARS-CoV-2 were associated with lower viral loads of SARS-CoV-2 Higher SARS-CoV-2 viral loads on admission were associated with a fatal outcome Cycle threshold values of different assays and target genes not readily comparable Abstract: Objectives: To examine the relationship between antibody status and cycle threshold (Ct) values, the prognostic value of the latter for COVID-19 patients, and the inter-assay comparability of SARS-CoV-2 Ct values. Methods: In 347 COVID-19 inpatients, SARS-CoV-2 Ct values (via reverse transcription-quantitative polymerase chain reaction) on admission were compared between 2 assays and correlated with the antibody response (in the course of the disease), the clinical course and the time since onset of symptoms. Results: Ct values for 2 of 3 target genes showed significant differences between the 2 assays used ( P =0.012 and P <0.0001). Ct values were significantly higher for antibody positive patients ( P <0.0001) and positively correlated with the amount of time since onset of symptoms (R: 0.332–0.363; P <0.001). Patients with fatal outcomes showed higher viral loads than survivors ( P <0.0001). Conclusions: Ct values depend strongly on assay used and target gene examined and should not be used as quantitative values to guide therapeutic or diagnostic decisions. The inverse association between antibody status and viral load suggests that antibodies contribute to the elimination of the virus, independent of the outcome, which is influenced by the viral load on admission and might depend more strongly on other parts of the immune response. … (more)
- Is Part Of:
- International journal of infectious diseases. Volume 110(2021)
- Journal:
- International journal of infectious diseases
- Issue:
- Volume 110(2021)
- Issue Display:
- Volume 110, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 110
- Issue:
- 2021
- Issue Sort Value:
- 2021-0110-2021-0000
- Page Start:
- 114
- Page End:
- 122
- Publication Date:
- 2021-09
- Subjects:
- SARS-CoV-2 -- COVID-19 -- RT-qPCR -- Ct value -- anti-SARS-CoV-2 antibodies
Communicable diseases -- Periodicals
Communicable Diseases -- Periodicals
Communicable diseases
Periodicals
Electronic journals
616.9 - Journal URLs:
- http://bibpurl.oclc.org/web/73769 ↗
http://www.journals.elsevier.com/international-journal-of-infectious-diseases/ ↗
http://www.sciencedirect.com/science/journal/12019712 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/12019712 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/12019712 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ijid.2021.07.014 ↗
- Languages:
- English
- ISSNs:
- 1201-9712
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.304750
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18907.xml